Workflow
ARCALYST
icon
Search documents
Kiniksa Pharmaceuticals International (KNSA) Earnings Call Presentation
2025-07-04 11:00
Corporate Presentation JULY 2023 Forward Looking Statements This presentation (together with any other statements or information that we may make in connection herewith) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to Kiniksa Pharmaceuticals, Ltd. (and its consolidated subsidiaries, collectively, unless context otherwise requires, "Kiniksa," "we," "us" or "our"). In some cases, you can identify forward looking statements by terms ...
5 Biotech Stocks to Buy in 2025 Amid Uncertain Macroenvironment
ZACKS· 2025-07-02 14:30
The volatile biotech industry has braved the global trade war relatively well in the first half of 2025. While a pause in the tariff war between the United States and China has lent some stability, ongoing geopolitical tensions continue to be a headwind. Nonetheless, given the continuous need for innovative medical treatments (regardless of the state of the economy), the dynamic biotech industry will continue to capture investors’ interest despite the inherent volatility and uncertain macroeconomic environm ...
Kiniksa Pharmaceuticals: Arcalyst Performs, KPL-387 Advancing Fast
Seeking Alpha· 2025-06-16 12:15
I publish my best ideas and top coverage on the Growth Stock Forum . If you're interested in finding great growth stocks, with a focus on biotech, consider signing up. We focus on attractive risk/reward situations and track each of our portfolio and watchlist stocks closely. To receive e-mail notifications for my public articles and blogs, please click the follow button . And to go deeper, sign up to Growth Stock Forum.Kiniksa Pharmaceuti cals (NASDAQ: KNSA ) is outperforming this year. The stock has advanc ...
Kiniksa Pharmaceuticals International (KNSA) 2025 Earnings Call Presentation
2025-06-06 09:25
Jefferies Global Healthcare Conference JUNE 5, 2025 Forward Looking Statements This presentation (together with any other statements or information that we may make in connection herewith) contains forward-looking statements with respect to Kiniksa Pharmaceuticals International, plc (and its consolidated subsidiaries, collectively, unless context otherwise requires, "Kiniksa," "we," "us" or "our"). In some cases, you can identify forward looking statements by terms such as "may," "will," "should," "expect," ...